Maze Therapeutics uses its Compass genetics platform to advance kidney and obesity drugs, with MZE829 Phase 2 data due in ...
Burundi, Egypt and Fiji eliminated trachoma; Guinea and Kenya eliminated sleeping sickness; and Niger became the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback